An interventional study of CF Nursing Program in Cystic Fibrosis, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-10.
Sponsored by University of Zurich · Not applicable, Interventional, and Supportive care
The purpose of this study is to evaluate the effect of a nursing program in patients with cystic fibrosis.
All patients living with cystic fibrosis will be asked by questionnaire before (November 2014) and after (September 2016) the implementation of the program about their satisfaction with treatment, trust in the CF-Team, adherence, self-efficacy, treatment burden and quality of life.
1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.
This study's enrollment of 35 is close to the median of 36 across 1,034 interventional studies indexed under Cystic Fibrosis.
Browse Cystic Fibrosis studies →University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: CF Nursing Program
Difference between baseline patient satisfaction and month 22
Self-reported patient satisfaction will be measured with a newly developped questionnaire.
Time frame: month 22
Difference between baseline adherence and month 22
Self-reported adherence to therapy will be measured with the Medication Adherence Report Scale (MARS) and a newly developped questionnaire.
Time frame: month 22
Difference between baseline self-efficacy and month 22
Self-reported self-efficacy to master the the therapeutic regimen will be measured with a newly developped questionnaire.
Time frame: month 22
Difference between baseline treatment burden and month 22
Self-reported treatment burden will be measured wiht a subscale of the CFQ-R.
Time frame: month 22
Difference between baseline trust and month 22
Self-reported trust will be measured with the short version of the Wake Forest Trust Scale.
Time frame: month 22
Difference between baseline information need and month 22
Information needs will be assessed with a subscale of the PICKER-questionnaire for patients with CF.
Time frame: month 22
Difference between baseline QoL and month 22
Self-reported QoL will be measured with the Cystic Fibrosis Questionnaire - revised (CFQ-R) and the VAS of the European Quality of Life Instrument - 5 dimensions (EQ-5D VAS).
Time frame: month 22
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Zurich